許智翔 Chih-Hsiang Hsu 主治醫師
許醫師專精於主動脈與周邊動靜脈疾病、洗腎血管建立維護、周邊血管超音波檢查。主動脈治療從傳統開胸腹手術到最新的微創支架治療；周邊動脈阻塞的導管或繞道手術，靜脈曲張微創雷射與硬化劑注射治療、深層靜脈栓塞導管等。主動脈剝離的手術成果已媲美歐美，直追日本。改良式葉克膜微創手術的發明人。目前亦為外科血管檢查室負責人。
學術機構典藏
論文
期刊論文
|
期刊論文／Journal Paper (作者群，論文題目，期刊名稱，出版年月，卷號(期別):頁次起迄) |
日期 | |
| 1 | 林有騫(Lin, You-Cian)、(Jeen-Chen Chen)、(Jiunn-Min Lin)、許智翔(Chih-Hsiang Hsu)、吳青(Ching-Feng Wu)、(Shao-Hsuan Kao)*，Differential serum proteomic signatures between acute aortic dissection and acute myocardial infarction，Biomedicines，2023 Jan，(): | 2023 . 01 |
| 2 | 何璟霖(Ching-Lin, Ho)、林俊閔(Jiunn-Miin Lin)、許智翔(Chih-Hsiang Hsu)、林有騫(Lin, You-Cian)*，A Comparison of the Short-Term Outcomes after Use of Aorto-Uni-Iliac Versus Bifurcated Endografts for Endovascular Repair of Ruptured Abdominal Aortic Aneurysms，ANNALS OF VASCULAR SURGERY，2022 Sep，(): | 2022 . 09 |
| 3 | 林俊閔(LIN JIUNN-MIIN)、許智翔(Chih-Hsiang Hsu)、陳勁辰(Jeen-Chen Chen)、高紹軒(Shao-Hsuan Kao)、林有騫(Lin, You-Cian)*，BCL-6 promotes the methylation of miR-34a by recruiting EZH2 and upregulates CTRP9 to protect ischemic myocardial injury，BIOFACTORS，2020 Dec，(): | 2020 . 12 |
研討會論文
|
研討會論文／Conference Papers (發表主題或論文名稱，研討會名稱，演講地點，研討會期間，受邀演講題目) |
日期 | |
| 1 | 套膜支架對於上臂及前臂之人工動靜脈廔管反覆狹窄病灶治療成效比較之回朔性研究，113年度外科聯合學術研討會，高雄醫學大學及附設中和紀念醫院，2024.03.16~2024.03.17， | 2024 . 03 |
| 2 | Modified pre-closure technique for percutaneous VA ECMO decannulation using Perclose ProGlide at bedside, with a total solution，血管外科年會2023，台北萬豪酒店，2023.09.02~2023.09.03， | 2023 . 09 |
| 3 | Pre-closure technique for percutaneous veno-arterial extracorporeal membrane oxygenation decannulation using Perclose ProGlide at bedside, with a total solution，Japan Endovascular Treatment Conference 2023，AKASAKA INTERCITY CONFERENCE CENTER，2023.05.26~2023.05.28， | 2023 . 05 |
| 4 | The result and rationale fo TEVAR procedure for Type B intramural hematoma of aorta，ESVS 33rd Annual Meeting，MESSE HALLS, HAMBURG，2019.09.24~2019.09.27， | 2019 . 09 |
| 5 | Four-year Surgical Results for Traumatic Aortic Injury in China Medical University Hospital, Mid-Taiwan，LINC ASIA-PACIFIC 2019，香港，2019.03.12~2019.03.13， | 2019 . 03 |
| 6 | 原始論文–使用1% polidocanol 靜脈內微泡沫治療主幹型及支幹型下肢靜脈曲張中國醫藥大學附設醫院一年結果，108年度外科聯合學會演講會，三軍總醫院，2019.03.16~2019.03.17， | 2019 . 03 |
| 7 | The Results Of Extending Indications For TEVAR Procedures To Nearly All Acute Type B Aortic Dissection，LINC ASIA-PACIFIC 2019，香港，2019.03.12~2019.03.13， | 2019 . 03 |
| 8 | The rationale and resulf of TEVAR procedure for Type B intramural hematoma of aorta，LINC ASIA-PACIFIC 2019，香港，2019.03.12~2019.03.13， | 2019 . 03 |
| 9 | Successful Rescue of Acute Visceral Ischemia after Thoracic Endovascular Aortic Repair for Chronic Type B Aortic Dissection at Proximal Descending Thoracic Aorta，Japan Endovascular Treatment Conference 2019，TKP Garden City Shinagawa 1F Shinagawa Goos, 3-13-3 Takanawa, Minato-ku, Tokyo 108-007, Japan，2019.02.22~2019.02.24， | 2019 . 02 |
| 10 | A case of acute limb ischemia with cholesterol emboli after endovascular approach，Japan Endovascular Treatment Conference 2019，TKP Garden City Shinagawa 1F Shinagawa Goos, 3-13-3 Takanawa, Minato-ku, Tokyo 108-007, Japan，2019.02.22~2019.02.24， | 2019 . 02 |
| 11 | Ultrasound-guided foam sclerotherapy using 1% polidocanol endovenous microfoam experience in China Medical University Hospital，Japan Endovascular Treatment Conference 2019，TKP Garden City Shinagawa 1F Shinagawa Goos, 3-13-3 Takanawa, Minato-ku, Tokyo 108-007, Japan，2019.02.22~2019.02.24， | 2019 . 02 |
| 12 | 4-year result of TEVAR procedure for acute type B aortic dissection in China Medical University Hospital，JET 2019, Japan Endovascular Treatment Conference 2019，TKP Garden City Shinagawa, Tokyo, Japan，2019.02.22~2019.02.24， | 2019 . 02 |
專書
暫無資料研究計畫
|
研究計畫／Research Grant (研究類型，研究計畫代號，主持人，補助或委託單位名稱，計畫名稱，計畫期間) |
日期 | |
| 1 | 個別型，DMR-111-050，林有騫(Lin, You-Cian)、郭正宜，附醫院內計畫，抗原嵌合接受體T細胞治療心臟纖維化之研究，2021.8.1~2022.7.31 | 2021 . 08 |
